Slate Path Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Slate Path Capital’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell
2019 Q4	$24.5M	Hold
2019 Q3	$9.63M	Buy